8-K current report · filed Jun 11, 2026

Cogent Biosciences, Inc. (COGT) 8-K Current Report: June 11, 2026

Item 5.07COGT overview

Short answer

Cogent Biosciences, Inc. (COGT) filed an 8-K current report with the SEC on June 11, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All three director nominees elected, with 120.2M–124.4M votes for each.

Cogent Biosciences, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • All three director nominees elected, with 120.2M–124.4M votes for each
  • PwC auditor ratification overwhelmingly approved, with 154.0M votes for and 399,367 against
  • Executive compensation advisory vote approved, with 129.2M votes for and 14.0M against
  • Broker non-votes totaled 11.2M for director elections and compensation vote, indicating non-voting shares on those proposals

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Cogent Biosciences, Inc. 8-K filings

Get the next COGT 8-K as it lands

Follow COGT for push alerts, or ask the research agent what this filing means.